Cutaneous TumorsNCT02166996
A Prospective Comparison of Suture Removal Time for Simple Surgical Defects of the Head and Neck
A study testing Suture removal time 7 days and Suture removal time14 days in people with Cutaneous Tumors, run by Sundsvall Hospital at 1 site in Sweden.
Trial summary
A single-center, prospective, randomized comparison with blinded assessment of cosmetic outcome. To compare cosmetic outcome of surgical defects of head and neck, repaired with non-resorbable monofilament sutures from the aspect of suture removal time 7 and 14 days. Read more about this study
- Who is it for?
- Ages 19 years and older
- Conditions the study is for
- Cutaneous Tumors
- What is being tested?
- Suture removal time 7 days and Suture removal time14 days
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 116 participants
- Where
- 1 siteSweden
- Study dates
- Apr 2011to Jun 2013
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 19 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Patient undergoing simple surgical excisions of suspected cutaneous malignancies in the head and neck and at least 18 years of age.
Who cannot join
- The use of local flaps or grafts.
- Not being able to understand the study protocol and the instructions given.
- Reoperation of the included wound/scar before study completion
Trial locations and contacts
1 site in 1 country.
About this study
A single-center, prospective, randomized comparison with blinded assessment of cosmetic outcome.
To compare cosmetic outcome of surgical defects of head and neck, repaired with non-resorbable monofilament sutures from the aspect of suture removal time 7 and 14 days. Data are gathered through a standardized form at the time of surgery concerning width and length of the surgical excisions, and if the patient has any systemic cortisone treatment or diabetes mellitus. At the time of surgery the patients are randomised to a suture time at 7 or 14 days postoperatively and all receive the same written information about postoperative care and restrictions.
Read more
Photographs of the scars are taken one month and one year after the procedure and rated using a visual analogue scale (VAS) by three independent assessors blinded to the intervention and suture time. The width of the scar is measured after one ear.
Study hypothesis is that leaving non-resorbable monofilament sutures in clean surgical wounds in the head and neck area for up to 14 days does not lead to poor cosmetic outcome.
Read the detailed description
Patients with cutaneous tumors undergoing excision of either a biopsy-proven or a suspected cutaneous malignancy in the head and neck area were between April 2010 and November 2011 included in the trial. Patients were not included if they were less than 18 years old or if skin flaps or grafts were used. For patients with several cutaneous changes removed at the same time each excision was registered separately. The excisions were performed by 11 surgeons. Four surgeons performed 66% of all the procedures.
The assisting nurse documented data in a standardized form at wound closure. Patient factors such as age, sex, diabetes and corticoid treatment was recorded. The width and the length of the skin excision were measured, the number of sutures placed in the wound was counted and the size of the needle was documented. Whether wound edges were undermined or not, whether the excision was oriented in the natural skin tension line and whether subcuticular sutures were used or not was recorded. Skin closure was with monofilament nylon (Ehilon®) sutures (size 5.0 or 6.0). After the sutures were placed, adhesive tapes were placed perpendicular to the wound edges. The location of each wound was marked on a cartoon for later use at follow up. Patients were randomized in blocks of 8 to removal of sutures after either 7 or 14 days. Randomization was by opening sealed envelopes after wound closure.Thus the surgeons were blinded to the suture removal time.
All Participants received written information about wound care on which they were instructed not to wet the wound for 48 hour after the operation. After that they could take showers but not take baths until the sutures were removed. After suture removal new adhesive tapes were placed in the same manner as before and participants were informed to leave these in place for at least 7 days and also to protect the scar from sunlight for at least 6 months. For practical reasons patients with several excisions were randomized to one suture removal time. Sutures were removed at the surgical department conducting the trial.
Photographs were taken at one and twelve months after skin closure. Photographs of the wounds were taken in a standardized fashion at one month follow up by using a Canon EOS 550 by a research assistent. At the twelve month follow up the scar width was measured at three points in the scar and a mean value was calculated. The photographs at the twelve month follow up were taken by a professional photographer using Canon EOS Mark 2.
The images were assessed by two blinded otorhinolaryngologist an one blinded plastic surgeon all three stationed at University Hospitals. Each image was rated twice. A validated visual analogue scale (VAS) for overall cosmesis was used. The VAS is a 100-mm line with 0 representing the worst cosmetic outcome possible and 100 representing the best possible result. The minimum clinically important difference (MCID) of the 100-mm VAS is 10-25 mm. Using the line as a continuous entity, the surgeons marked the line, where it in their opinion best reflected the overall cosmetic outcome. The score was then measured in millimeters from the 0 point. Raters were instructed to take into account variables such as scar width, contour irregularities, step-off borders and presence of inflammation. Raters were also asked to note (twice) whether they noticed puncture marks in the scars or not.
This study had a power of 90% to discriminate with a MCID of 15-mm on the VAS for which 37 patients/scars were required in each group (p=0.05). This was based on using a standard deviation of 19.4 in a previous study using the VAS. Statistical analysis was performed with computer software (Microsoft Excel 2011 and SPSS) together with a statistician from the Department of Research and Development at Sundsvall hospital.
Ethical committee approval was granted for the study, and informed written consent was obtained before patient participation. The study was conducted at an Otorhinolaryngology division of the Surgical Center at Sundsvall Hospital receiving referrals from the dermatology division, primary health sector and private practicing otorhinolaryngologists (ORLs).
- Conditions
- Cutaneous Tumors
- Being tested
- Suture removal time 7 days, Suture removal time14 days
- Medical subject headings
- Skin Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Suture removal time 7 daysProcedure or surgery
To compare cosmetic outcome of surgical defects of head and neck, repaired with non-resorbable monofilament nylon sutures from the aspect of suture removal time 7 days.
Suture removal time14 daysProcedure or surgery
To compare cosmetic outcome of surgical defects of head and neck, repaired with non-resorbable monofilament nylon sutures from the aspect of suture removal time 14 days
| Study group | Role | What they receive |
|---|---|---|
| A | Active comparator | Suture removal time 7 days. Receives: Procedure: Suture removal time 7 days |
| B | Experimental | Suture removal time 14 days. Receives: Procedure: Suture removal time14 days |
What is being measured
The primary outcome is the main question the study is designed to answer.
Cosmetic assessment of scar
assessment of scar with Visual Analog Cosmesis Scale after one month and one year. 3 blinded assessors.
Measured: One month and one year
Secondary outcomes (1)
width of scar
with a mm-scale measure the width of the scar in 3 locations.
Measured: one year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Jun 2014 (estimated)
- Study startApr 2011
- Primary completionJan 2013
- Study completionJun 2013
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Cutaneous TumorsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Care provider, Outcomes assessor
- Enrolment
- 116 participants (actual)
Sponsor and investigators
- Lead sponsor
- Sundsvall Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Sarah Maleki, MD, Principal investigator, Sundsvall HospitalEva Westman, MD, PhD, Study director, Sundsvall Hospital, Umeå University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02166996
- Sponsor's protocol ID
- Dnr 2011-56-31M
- Status last verified
- Dec 2012
- First submitted
- 31 Mar 2013
- Last updated
- 18 Jun 2014
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 18 Jun 2014. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Prospective Comparison of Suture Removal Time for Simple Surgical Defects of the Head and Neck
- ClinicalTrials.gov ID
- NCT02166996
- Acronym / sponsor ID
- Dnr 2011-56-31M
- Conditions
- Cutaneous Tumors
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 116 participants (actual)
- Lead sponsor
- Sundsvall HospitalUniversity, hospital or other
- Study start
- Apr 2011
- Primary completion
- Jan 2013 (actual)
- Study completion
- Jun 2013 (actual)
- First posted
- 18 Jun 2014 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
A single-center, prospective, randomized comparison with blinded assessment of cosmetic outcome.
To compare cosmetic outcome of surgical defects of head and neck, repaired with non-resorbable monofilament sutures from the aspect of suture removal time 7 and 14 days. Data are gathered through a standardized form at the time of surgery concerning width and length of the surgical excisions, and if the patient has any systemic cortisone treatment or diabetes mellitus. At the time of surgery the patients are randomised to a suture time at 7 or 14 days postoperatively and all receive the same written information about postoperative care and restrictions.
Photographs of the scars are taken one month and one year after the procedure and rated using a visual analogue scale (VAS) by three independent assessors blinded to the intervention and suture time. The width of the scar is measured after one ear.
Study hypothesis is that leaving non-resorbable monofilament sutures in clean surgical wounds in the head and neck area for up to 14 days does not lead to poor cosmetic outcome.
Detailed description
Patients with cutaneous tumors undergoing excision of either a biopsy-proven or a suspected cutaneous malignancy in the head and neck area were between April 2010 and November 2011 included in the trial. Patients were not included if they were less than 18 years old or if skin flaps or grafts were used. For patients with several cutaneous changes removed at the same time each excision was registered separately. The excisions were performed by 11 surgeons. Four surgeons performed 66% of all the procedures.
The assisting nurse documented data in a standardized form at wound closure. Patient factors such as age, sex, diabetes and corticoid treatment was recorded. The width and the length of the skin excision were measured, the number of sutures placed in the wound was counted and the size of the needle was documented. Whether wound edges were undermined or not, whether the excision was oriented in the natural skin tension line and whether subcuticular sutures were used or not was recorded. Skin closure was with monofilament nylon (Ehilon®) sutures (size 5.0 or 6.0). After the sutures were placed, adhesive tapes were placed perpendicular to the wound edges. The location of each wound was marked on a cartoon for later use at follow up. Patients were randomized in blocks of 8 to removal of sutures after either 7 or 14 days. Randomization was by opening sealed envelopes after wound closure.Thus the surgeons were blinded to the suture removal time.
All Participants received written information about wound care on which they were instructed not to wet the wound for 48 hour after the operation. After that they could take showers but not take baths until the sutures were removed. After suture removal new adhesive tapes were placed in the same manner as before and participants were informed to leave these in place for at least 7 days and also to protect the scar from sunlight for at least 6 months. For practical reasons patients with several excisions were randomized to one suture removal time. Sutures were removed at the surgical department conducting the trial.
Photographs were taken at one and twelve months after skin closure. Photographs of the wounds were taken in a standardized fashion at one month follow up by using a Canon EOS 550 by a research assistent. At the twelve month follow up the scar width was measured at three points in the scar and a mean value was calculated. The photographs at the twelve month follow up were taken by a professional photographer using Canon EOS Mark 2.
The images were assessed by two blinded otorhinolaryngologist an one blinded plastic surgeon all three stationed at University Hospitals. Each image was rated twice. A validated visual analogue scale (VAS) for overall cosmesis was used. The VAS is a 100-mm line with 0 representing the worst cosmetic outcome possible and 100 representing the best possible result. The minimum clinically important difference (MCID) of the 100-mm VAS is 10-25 mm. Using the line as a continuous entity, the surgeons marked the line, where it in their opinion best reflected the overall cosmetic outcome. The score was then measured in millimeters from the 0 point. Raters were instructed to take into account variables such as scar width, contour irregularities, step-off borders and presence of inflammation. Raters were also asked to note (twice) whether they noticed puncture marks in the scars or not.
This study had a power of 90% to discriminate with a MCID of 15-mm on the VAS for which 37 patients/scars were required in each group (p=0.05). This was based on using a standard deviation of 19.4 in a previous study using the VAS. Statistical analysis was performed with computer software (Microsoft Excel 2011 and SPSS) together with a statistician from the Department of Research and Development at Sundsvall hospital.
Ethical committee approval was granted for the study, and informed written consent was obtained before patient participation. The study was conducted at an Otorhinolaryngology division of the Surgical Center at Sundsvall Hospital receiving referrals from the dermatology division, primary health sector and private practicing otorhinolaryngologists (ORLs).
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (care provider, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| A | Active comparator | Procedure: Suture removal time 7 daysSuture removal time 7 days. |
| B | Experimental | Procedure: Suture removal time14 daysSuture removal time 14 days. |
Who may qualify
- Ages
- 19 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Patient undergoing simple surgical excisions of suspected cutaneous malignancies in the head and neck and at least 18 years of age.
Key exclusion criteria (3 listed)
- The use of local flaps or grafts.
- Not being able to understand the study protocol and the instructions given.
- Reoperation of the included wound/scar before study completion
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Suture removal time 7 daysTo compare cosmetic outcome of surgical defects of head and neck, repaired with non-resorbable monofilament nylon sutures from the aspect of suture removal time 7 days. | Procedure or surgery | A |
| Suture removal time14 daysTo compare cosmetic outcome of surgical defects of head and neck, repaired with non-resorbable monofilament nylon sutures from the aspect of suture removal time 14 days | Procedure or surgery | B |
Primary outcome
Cosmetic assessment of scar
Time frame: One month and one year
assessment of scar with Visual Analog Cosmesis Scale after one month and one year. 3 blinded assessors.
1 secondary outcome
width of scar
Time frame: one year
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Jun 2014.
Related trials for Cutaneous Tumors
RecruitingPhase 1/2
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Solid Tumor, Non-Small Cell Lung Cancer
RecruitingPhase 1
IL-17 Blockade to Decrease irAEs (REPLAY)
Metastatic Melanoma
Enrolling by invitationObservational study
Natural History Study of Early Life Exposures in Agriculture (ELEA)
Prostate Cancer, Leukemia
RecruitingObservational study
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
Cutaneous T-cell Lymphoma, Sezary Syndrome
RecruitingPhase 1
A Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint Therapy
Melanoma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Sarah Maleki, MD principal investigator
Sundsvall Hospital
Eva Westman, MD, PhD study director
Sundsvall Hospital, Umeå University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Suture removal time 7 days and Suture removal time14 days in people with Cutaneous Tumors, run by Sundsvall Hospital at 1 site in Sweden.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 18 Jun 2014. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Cosmetic assessment of scar (time frame: One month and one year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jun 2014.